WallStreetZenWallStreetZen

NASDAQ: VAXX
Vaxxinity Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VAXX

Based on 1 analyst offering 12 month price targets for Vaxxinity Inc.
Min Forecast
$7.00+600%
Avg Forecast
$7.00+600%
Max Forecast
$7.00+600%

Should I buy or sell VAXX stock?

Based on 1 analyst offering ratings for Vaxxinity Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VAXX stock forecasts and price targets.

VAXX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-09-08

1 of 1

Forecast return on equity

Is VAXX forecast to generate an efficient return?
Company
N/A
Industry
-0.65%
Market
30.3%

Forecast return on assets

Is VAXX forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.13%

VAXX revenue forecast

What is VAXX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$13.4M
Avg 2 year Forecast
$30.8M
Avg 3 year Forecast
$62.1M

VAXX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VAXX$1.00$7.00+600.00%Buy
OTLK$0.48$4.50+829.75%Buy
IMAB$1.55$22.00+1,319.35%Strong Buy
TNYA$1.90$18.00+847.37%Strong Buy
ACHV$5.86$19.00+224.23%Strong Buy
View Top Biotech Stocks

Vaxxinity Stock Forecast FAQ

Is Vaxxinity Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VAXX) stock is to Buy VAXX stock.

Out of 1 analyst, 0 (0%) are recommending VAXX as a Strong Buy, 1 (100%) are recommending VAXX as a Buy, 0 (0%) are recommending VAXX as a Hold, 0 (0%) are recommending VAXX as a Sell, and 0 (0%) are recommending VAXX as a Strong Sell.

If you're new to stock investing, here's how to buy Vaxxinity stock.

What is VAXX's revenue growth forecast for 2024-2026?

(NASDAQ: VAXX) Vaxxinity's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.56%.

Vaxxinity's revenue in 2023 is $0.On average, 1 Wall Street analysts forecast VAXX's revenue for 2024 to be $1,698,395,382, with the lowest VAXX revenue forecast at $1,698,395,382, and the highest VAXX revenue forecast at $1,698,395,382. On average, 1 Wall Street analysts forecast VAXX's revenue for 2025 to be $3,903,774,459, with the lowest VAXX revenue forecast at $3,903,774,459, and the highest VAXX revenue forecast at $3,903,774,459.

In 2026, VAXX is forecast to generate $7,870,921,880 in revenue, with the lowest revenue forecast at $7,870,921,880 and the highest revenue forecast at $7,870,921,880.

What is VAXX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: VAXX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%.

What is VAXX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VAXX price target, the average VAXX price target is $7.00, with the highest VAXX stock price forecast at $7.00 and the lowest VAXX stock price forecast at $7.00.

The Wall Street analyst predicted that Vaxxinity's share price could reach $7.00 by Sep 8, 2024. The average Vaxxinity stock price prediction forecasts a potential upside of 600% from the current VAXX share price of $1.00.

What is VAXX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: VAXX) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.